drugset / Trial / NCT00741351

Anesthesiological Strategies in Elective Craniotomy

NCT00741351

Phase 3 Completed 411 enrolled Azienda Ospedaliera San Gerardo di Monza
RandomizedParallel-groupDouble-blindTreatment

Summary

This protocol, NeuroMorfeo, aims to assess equivalence between volatile and intravenous anesthetics for neurosurgical procedures.

Timeline

Start
2007-12
Primary completion
2009-03
Completion
2009-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 0.7 ug/kg
Subject Fentanyl Other / unclassified 2 ug/kg
Subject Fentanyl Other / unclassified 3 ug/kg
Subject Propofol Small molecule 6 mg/kg Intravenous
Subject Remifentanil Small molecule 0.05 ug/kg
Subject Remifentanil Small molecule 0.1 ug/kg
Subject Sevoflurane Other / unclassified 0.75 % Inhaled
Subject Sevoflurane Other / unclassified 1.25 % Inhaled

Indications

No indication recorded.